Related Articles for PubMed (Select 18826578)

Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP.

J Urol. 2006 Oct;176(4 Pt 1):1354-61; discussion 1361-2.

PMID: 16952631 [PubMed - indexed for MEDLINE]

10:

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder.

Zietman AL, Grocela J, Zehr E, Kaufman DS, Young RH, Althausen AF, Heney NM, Shipley WU.

Urology. 2001 Sep;58(3):380-5.

PMID: 11549485 [PubMed - indexed for MEDLINE]

11:

Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.

Stein JP, Cai J, Groshen S, Skinner DG.

J Urol. 2003 Jul;170(1):35-41.

PMID: 12796639 [PubMed - indexed for MEDLINE]

12:

[Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?]

Kriegmair M, Waidelich R, Baumgartner R, Lumper W, Ehsan A, Hofstetter A.

Urologe A. 1994 Jul;33(4):276-80. German.

PMID: 7941172 [PubMed - indexed for MEDLINE]

13:

Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder.

Harada K, Sakai I, Kurahashi T, Muramaki M, Yamanaka K, Hara I, Eto H, Miyake H.

Int Urol Nephrol. 2006;38(1):49-55.

PMID: 16502052 [PubMed - indexed for MEDLINE]

14:

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique.

Borgaonkar S, Jain A, Bollina P, McLaren DB, Tulloch D, Kerr GR, Howard GC.

Clin Oncol (R Coll Radiol). 2002 Apr;14(2):141-7.

PMID: 12069124 [PubMed - indexed for MEDLINE]

15:

Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

Dhar NB, Jones JS, Reuther AM, Dreicer R, Campbell SC, Sanii K, Klein EA.

BJU Int. 2008 Apr;101(8):969-72. Epub 2007 Nov 13.

PMID: 18005201 [PubMed - indexed for MEDLINE]

16:

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.

BJU Int. 2004 Dec;94(9):1258-62.

PMID: 15610101 [PubMed - indexed for MEDLINE]

17:

Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.

Alsheikh A, Mohamedali Z, Jones E, Masterson J, Gilks CB.

Mod Pathol. 2001 Apr;14(4):267-72.

PMID: 11301341 [PubMed - indexed for MEDLINE]

18:

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID: 16813876 [PubMed - indexed for MEDLINE]

19:

[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]

Słojewski M.

Ann Acad Med Stetin. 2000;46:217-29. Polish.

PMID: 11712306 [PubMed - indexed for MEDLINE]

20:

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.

J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422.

PMID: 17085118 [PubMed - indexed for MEDLINE]

Recent Activity